retatrutide unauthorized sales The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers. "All of a sudden, you have pharmacies marketing directly ⚠️ BEWARE OF RETATRUTIDE SOLD

It is sometimes prescribed off-label for weight loss

Based on Phase 2 trial data, the most common early side effects are nausea, vomiting, diarrhoea, constipation, and reduced appetite, consistent with the GLP-1 receptor agonist class

These drugs assist in controlling blood sugar levels by doing this which is particularly beneficial for patients with type 2 diabetes

doi:10.1016/j.ajcnut.2025.04.023 2 DiNicolantonio JJ, Berger A

Kim, K.-S

Regulatory bodies like the Food and Drug Administration (FDA) and consumer advocacy groups are now calling for more transparent labeling and stricter post-market surveillance of these medications to ensure patient safety